| Miss Samantha Michelle Moody, MS, CCC-SLP | |
|
Madigan Army Medical Center 9040 Jackson Ave, Tacoma, WA 98431-4939 | |
| (253) 968-2252 | |
| Not Available |
| Full Name | Miss Samantha Michelle Moody |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | Madigan Army Medical Center 9040 Jackson Ave, Tacoma, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124545777 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 60898338 (Washington) | Secondary |
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Samantha Michelle Moody, MS, CCC-SLP 1161 Nw Dragonstone St, Bremerton, WA 98311-3502 Ph: (360) 819-9844 | Miss Samantha Michelle Moody, MS, CCC-SLP Madigan Army Medical Center 9040 Jackson Ave, Tacoma, WA 98431-4939 Ph: (253) 968-2252 |
News Archive
Bionovo, Inc. today announced second quarter highlights and financial results for the three months ended June 30, 2010.
Calypso Medical Technologies, Inc., a developer of non-ionizing real-time localization technology used for the precise tracking of tumor targets, and Cancer Treatment Centers of America, a national network of hospitals providing a comprehensive, fully integrative approach to cancer treatment, announced today that with the installation of the Calypso System at the CTCA at Southwestern Regional Medical Center in Tulsa, Okla., Calypso's real-time tumor tracking technology is now available at all CTCA centers nationwide.
When it comes to removing very dilute concentrations of pollutants from water, existing separation methods tend to be energy- and chemical-intensive. Now, a new method developed at MIT could provide a selective alternative for removing even extremely low levels of unwanted compounds.
Inspiration Biopharmaceuticals, Inc. today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds.
Children under age 5 who underwent minor surgery requiring anesthesia had a 26 percent increased risk of later diagnosis with a mental disorder. However, the timing of the procedure did not affect this risk, according to a new study at Columbia University's Mailman School of Public Health and College of Physicians and Surgeons.
› Verified 7 days ago
Andrea Lynn Rottier, LL Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4301 S Pine St, Ste 219, Tacoma, WA 98409 Phone: 253-476-6550 | |
Janet Kobayashi-hobson, CCC Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
Christine L Camp, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2106 E 44th St, Tacoma, WA 98404 Phone: 253-571-2908 | |
Ann S Lewis, B.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1202 S 76th St, Tacoma, WA 98408 Phone: 253-571-4579 | |
Angela Curtis, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-7919 | |
Porsche Maneice, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 242 St Helens Ave, Tacoma, WA 98402 Phone: 253-627-3833 | |
Peggy Lesniak, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1310 S Union Ave Ste A100, Tacoma, WA 98405 Phone: 253-383-2423 |